0000000000641621

AUTHOR

Borja Ibanez

showing 4 related works from this author

Lipidomic profiling identifies signatures of metabolic risk

2020

Background: Metabolic syndrome (MetS), the clustering of metabolic risk factors, is associated with cardiovascular disease risk. We sought to determine if dysregulation of the lipidome may contribute to metabolic risk factors. Methods: We measured 154 circulating lipid species in 658 participants from the Framingham Heart Study (FHS) using liquid chromatography-tandem mass spectrometry and tested for associations with obesity, dysglycemia, and dyslipidemia. Independent external validation was sought in three independent cohorts. Follow-up data from the FHS were used to test for lipid metabolites associated with longitudinal changes in metabolic risk factors. Results: Thirty-nine lipids were…

Male0301 basic medicineResearch paperdhSL dihydrosphingolipidBMI body mass indexlcsh:MedicineATHEROGENIC LIPOPROTEINSBioinformaticsFHS Framingham Heart StudyPC phosphatidylcholinePESA Progression of Early Subclinical Atherosclerosis0302 clinical medicineFramingham Heart StudyRisk FactorsSAFHS San Antonio Family Heart StudyLC-MS/MS liquid chromatography-tandem mass spectrometryMedicineLongitudinal StudiesMetabolic riskPLASMA SPHINGOLIPID METABOLISMPOPULATIONlcsh:R5-920education.field_of_studySPHINGOMYELINCE cholesteryl esterDysglycemiaGeneral MedicineMiddle AgedLipidomePS phosphatidylserineCardiovascular diseaseLipidsMetabolic syndrome3. Good healthCARDIOVASCULAR-DISEASE030220 oncology & carcinogenesisHEARTMetS metabolic syndromeFemaleDisease SusceptibilityLGPL lysoglycerophospholipidSL sphingolipidlcsh:Medicine (General)LPE lysophosphatidylethanolamineAdultFDR false discovery rateTAG triacylglycerolPopulationCer ceramideCVD cardiovascular diseasePE phosphatidylethanolamineDENSITY-LIPOPROTEINRisk AssessmentGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesAnimalsHumanseducationT2DM type II diabetes mellitusAgedLPC lysophosphatidylcholineSM sphingomyelinbusiness.industryCERAMIDElcsh:RHDL-C High density lipoprotein cholesterolBiomarkerLipid Metabolismmedicine.diseaseObesitySphingolipidCross-Sectional Studies030104 developmental biologyDyslipidemiaERF Erasmus Family StudyLipidomicsMetabolic syndromeINDUCED INSULIN-RESISTANCEbusinessDAG diacylglycerolBody mass indexBiomarkersDyslipidemiaMRM multiple reaction monitoringFASTING GLUCOSE
researchProduct

Beta-3 adrenergic receptor overexpression reverses aortic stenosis-induced heart failure and restores balanced mitochondrial dynamics

2022

25 p.-7 fig.

Medicina InvestigacióPhysiologyMedicinaEnfermedad cardiovascularHipertrofia ventricular izquierdaMice TransgenicHeart failureBeta adrenergic systemMitochondrial DynamicsReceptores adrenérgicos betaMicePhysiology (medical)HumansAnimalsMyocytes CardiacMetabolismoHeart FailureAortic stenosisMetalloendopeptidasesAortic Valve StenosisHypertrophyMitochondriaMetabolismReceptors Adrenergic beta-3Hypertrophy Left VentricularCardiology and Cardiovascular MedicineEstenosis de la válvula aórtica
researchProduct

Nanoparticles as Contrast Agents for MRI of Atherosclerotic Lesions

2008

Nanoparticle contrast agents for MRI may aid in identifying atherosclerotic lesions that give rise to ischemic events by means of penetration and retention in the plaque. These imaging agents may provide valuable information regarding plaque characteristics which can help determine the risk of plaque rupture. By increasing molecular flexibility or adding a means of specifically targeting ligands via antibody or peptide, nanoparticles can enhance certain regions of the atherosclerotic plaque. The development of single contrast agents detectable with multiple imaging modalities may further improve our ability to detect and characterize atherosclerosis in clinical and preclinical applications.…

lcsh:Diseases of the circulatory (Cardiovascular) systembusiness.industryPlaque ruptureClinical scienceBioinformaticsOriginal researchImaging modalitieslcsh:RC666-701Drug deliverySingle contrastMedicineCancer geneCardiology and Cardiovascular MedicinebusinessTargeting ligandsClinical medicine. Cardiology
researchProduct

Contemporary differences between men and women with acute coronary syndromes: CIAM multicenter registry.

2019

AIM Differences exist in the diagnosis and treatment of acute coronary syndrome (ACS) between men and women. However, recent advancements in the management of ACSs might have attenuated this sex gap. We evaluated the status of ACS management in a multicenter registry in 10 tertiary Spanish hospitals. METHODS We enrolled 1056 patients in our study, including only those with type 1 myocardial infarctions or unstable angina presumably not related to a secondary cause in an 'all-comers' design. RESULTS The women enrolled (29%) were older than men (71.0 ± 12.8 vs. 64.0 ± 12.3, P = 0.001), with a higher prevalence of hypertension (71.0 vs. 56.5%, P < 0.001), insulin-treated diabetes (13.7 vs. 7.9…

MaleAcute coronary syndromemedicine.medical_specialtymedicine.medical_treatmentMyocardial Infarction030204 cardiovascular system & hematologyRevascularizationRisk AssessmentAngina03 medical and health sciences0302 clinical medicineSex FactorsRisk FactorsInternal medicinePalpitationsPrevalenceMedicineHumans030212 general & internal medicineAngina UnstableProspective StudiesRegistriesAcute Coronary SyndromeHealthcare DisparitiesProspective cohort studyAgedAged 80 and overbusiness.industryUnstable anginaAge FactorsGeneral MedicineHealth Status DisparitiesMiddle Agedmedicine.diseaseTreatment OutcomeSpainFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessDyslipidemiaKidney diseaseJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct